Stock listing

NASDAQ:CASC Cascadian Therapeutics Inc Stock

Follow Cascadian Therapeutics Inc into a list and get an email when it puts out news.

Last close · NASDAQ:CASC

$10.02 USD

Close on Mar 9, 2018 · No longer trades

Nov 29, 2016 to last close +77.3% · weekly closes, Nov 29, 2016 – Mar 9, 2018
Lowest – highest close
$3.21 – $10.05 USDSince Nov 29, 2016 · lowest Jun 14, 2017 · highest Jan 31, 2018

Delisted NASDAQ:CASC no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:CASC
Asset type
Stock
Exchange
NASDAQ
Currency
USD

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Ted W Love
Other companies: Lisata Therapeutics, Inc. (Director · Since at least Sep 17, 2026); Jazz Pharmaceuticals plc (Director · Since at least Dec 1, 2025); Gilead Sciences, Inc. (Director · Since at least Feb 1, 2024); Structure Therapeutics, Inc. (Director · Since at least Aug 3, 2023); Royalty Pharma plc (Director · Since at least Jul 30, 2020); Seagen Inc (Director · Aug 16, 2020 – Dec 14, 2023 · Past); Portola Pharmaceuticals Inc (Director · Sep 18, 2019 – Jul 2, 2020 · Past); Global Blood Therapeutics Inc (President and CEO, Director · Aug 11, 2015 – Oct 5, 2022 · Past); Savara, Inc. (Director · Sep 5, 2012 – Jun 19, 2013 · Past); Humanigen Inc (Director · Aug 10, 2012 – Jul 10, 2015 · Past); Amicus Therapeutics Inc (Director · Jun 13, 2012 – Jun 4, 2020 · Past); Bio-Rad Laboratories, Inc. (Director · Mar 24, 2010 – Mar 24, 2010 · Past); Onyx Pharmaceuticals Inc (EVP, R&D and Tech. Operations · Feb 1, 2010 – Jul 25, 2012 · Past); Affymax Inc (Director · Dec 14, 2006 – Jun 13, 2012 · Past); Santarus Inc (Director · Jun 7, 2006 – Jan 2, 2014 · Past); Oruka Therapeutics, Inc. (Director · Mar 7, 2006 – Feb 5, 2010 · Past)
Director · Sep 5, 2013 – Mar 9, 2018 · Past
Robert Azelby
Other companies: Tango Therapeutics, Inc. (Chairman; Former President and CEO, Eliem Therapeutics, Inc. · Since at least Jun 19, 2026); Autolus Therapeutics plc (Director · Since at least Mar 18, 2026); Terns Pharmaceuticals, Inc. (Director · Since at least Feb 20, 2025); Cardinal Health, Inc. (Director · Since at least Mar 1, 2024); ADC Therapeutics SA (Director · Since at least Jan 2, 2024); Aduro Biotech Inc (Director · Apr 10, 2023 – Aug 11, 2023 · Past); Climb Bio, Inc. (President & CEO, Director · Aug 9, 2021 – Oct 31, 2022 · Past); Immunomedics Inc (Director · Feb 26, 2020 – Oct 23, 2020 · Past); Clovis Oncology Inc (Director · Oct 11, 2018 – Jun 10, 2021 · Past); Alder BioPharmaceuticals Inc (President and CEO, Director · Jun 13, 2018 – Oct 22, 2019 · Past); Juno Therapeutics Inc (EVP & Chief Commercial Officer · Nov 1, 2015 – Mar 5, 2018 · Past)
Director · Mar 31, 2017 – Mar 9, 2018 · Past
Steven P James
Other companies: Allakos Inc (Director · Jul 18, 2018 – May 15, 2025 · Past); Ocera Therapeutics Inc (Director · Sep 17, 2014 – Dec 11, 2017 · Past)
Director · Feb 26, 2015 – Mar 9, 2018 · Past
Scott Robert PetersonChief Scientific Officer · Jun 19, 2012 – Mar 9, 2018 · Past
Shashi K KaranCorporate Controller · Mar 7, 2009 – Sep 28, 2010 · Past

Open People

Log in to ask 6ix AI your own questions about Cascadian Therapeutics Inc.